Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enliven Treateutics

23.00
+0.55002.45%
Post-market: 23.000.00000.00%16:20 EDT
Volume:416.24K
Turnover:9.52M
Market Cap:1.32B
PE:-11.90
High:23.24
Open:22.41
Low:21.80
Close:22.45
Loading ...
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

Correspondence

Form CORRESP - Correspondence
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 24, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 21, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]